Valle Franco
Insider CIK 1699848 · EIDX Senior Vice President, Finance · BMEA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion, Inc. | A Award | 2024-11-30 | 2024-12-02 | 495 | $6.15 | $3.0K | 42,995 | SEC↗ |
| BMEA Biomea Fusion, Inc. | P Buy | 2024-06-11 | 2024-06-12 | 12,509 | $4.43 | $55.4K | 42,500 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award | 2024-05-31 | 2024-06-12 | 4,448 | $3.78 | $16.8K | 29,991 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2024-01-17 | 2024-01-18 | 145,245 | — | $0 | 145,245 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award | 2023-11-30 | 2023-12-01 | 1,345 | $3.78 | $5.1K | 25,543 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award | 2023-05-31 | 2023-06-02 | 4,273 | $3.78 | $16.2K | 24,198 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2023-01-06 | 2023-01-10 | 126,300 | — | $0 | 126,300 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award | 2022-11-30 | 2022-12-02 | 2,518 | $3.78 | $9.5K | 19,925 | SEC↗ |
| BMEA Biomea Fusion, Inc. | P Buy | 2022-11-11 | 2022-11-14 | 4,100 | $7.63 | $31.3K | 17,407 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award | 2022-05-31 | 2022-06-01 | 3,307 | $4.67 | $15.4K | 13,307 | SEC↗ |
| BMEA Biomea Fusion, Inc. | P Buy | 2022-01-14 | 2022-01-18 | 10,000 | $8.68 | $86.8K | 10,000 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2021-12-04 | 2021-12-07 | 144,770 | — | $0 | 144,770 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 165,000 | — | $0 | 165,000 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | D To issuer deriv | 2021-01-26 | 2021-01-28 | 24,350 | — | $0 | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2021-01-12 | 2021-01-13 | 1,747 | — | $0 | 24,350 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2021-01-12 | 2021-01-13 | 1,747 | $7.24 | $12.6K | 1,747 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-12 | 2021-01-13 | 1,747 | $125.45 | $219.2K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2021-01-11 | 2021-01-13 | 1,500 | — | $0 | 26,097 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-11 | 2021-01-13 | 1,500 | $125.61 | $188.4K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2021-01-11 | 2021-01-13 | 1,500 | $7.24 | $10.9K | 1,500 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2020-11-09 | 2020-11-10 | 1,623 | — | $0 | 27,597 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-11-09 | 2020-11-10 | 1,623 | $74.93 | $121.6K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2020-11-09 | 2020-11-10 | 1,623 | $7.24 | $11.8K | 1,623 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2020-10-08 | 2020-10-09 | 5,199 | — | $0 | 29,220 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2020-10-08 | 2020-10-09 | 5,199 | $7.24 | $37.6K | 5,199 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-10-08 | 2020-10-09 | 5,199 | $74.85 | $389.1K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2020-10-07 | 2020-10-09 | 5,000 | — | $0 | 34,419 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2020-10-07 | 2020-10-09 | 5,000 | $7.24 | $36.2K | 5,444 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-10-07 | 2020-10-09 | 5,444 | $75.08 | $408.7K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award | 2020-05-31 | 2020-06-05 | 444 | $41.57 | $18.5K | 444 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2020-04-20 | 2020-04-22 | 2,000 | — | $0 | 39,419 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-04-20 | 2020-04-22 | 2,000 | $49.79 | $99.6K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2020-04-20 | 2020-04-22 | 2,000 | $7.24 | $14.5K | 2,000 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2020-03-26 | 2020-03-30 | 5,000 | — | $0 | 41,419 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2020-03-26 | 2020-03-30 | 5,000 | $7.24 | $36.2K | 5,000 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-03-26 | 2020-03-30 | 3,000 | $47.87 | $143.6K | 2,000 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-03-26 | 2020-03-30 | 2,000 | $48.85 | $97.7K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 3,000 | — | $0 | 46,419 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 3,000 | $7.24 | $21.7K | 3,000 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 1,000 | $53.06 | $53.1K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 2,000 | $51.96 | $103.9K | 1,000 | SEC↗ |